We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 890 results
  1. Silymarin

    Reference work entry 2024
  2. The effects of silymarin consumption on inflammation and oxidative stress in adults: a systematic review and meta-analysis

    Background

    Owing to the rich phytochemical content of Silymarin, it may effectively manage inflammation and oxidative stress. We, therefore, aimed to...

    Hossein Bahari, Mostafa Shahraki Jazinaki, ... Mahsa Malekahmadi in Inflammopharmacology
    Article 19 February 2024
  3. A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity

    Purpose

    Although doxorubicin chemotherapy is commonly applied for treating different malignant tumors, cardiotoxicity induced by this chemotherapeutic...

    Mandeep Singh, Mustafa M. Kadhim, ... Bagher Farhood in Cancer Cell International
    Article Open access 10 May 2023
  4. Neuroprotective effects of silymarin in 3-nitropropionic acid-induced neurotoxicity in male mice: improving behavioral deficits by attenuating oxidative stress and neuroinflammation

    3-Nitropropionic acid (3-NP) is strongly believed to be an irreversible inhibitor of mitochondrial complex II, leading to neural damage. This study...

    Rasool Haddadi, Shahla Eyvari-Brooshghalan, ... Afsoon Daneshvar in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 17 October 2023
  5. Administration of α-lipoic acid and silymarin attenuates aggression by modulating endocrine, oxidative stress and inflammatory pathways in mice

    Aggression, a highly prevalent behavior among all the psychological disorders having strong association with psychiatric imbalance, neuroendocrine...

    Adnan Karim, Fareeha Anwar, ... Muhammad Ajmal Shah in Metabolic Brain Disease
    Article 17 July 2023
  6. A comparative study on the preparation and evaluation of solubilizing systems for silymarin

    Silymarin (SM) exhibits clinical efficacy in treating liver injuries, cirrhosis, and chronic hepatitis. However, its limited water solubility and low...

    Zhenzhen Chen, Wenhao Gao, ... Hongtao Song in Drug Delivery and Translational Research
    Article 14 November 2023
  7. Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data

    Purpose

    Thus far, silymarin has been examined in several studies for prevention or treatment of various chemotherapy or radiotherapy-induced adverse...

    Mahsa Ghodousi, Hedyieh Karbasforooshan, ... Sepideh Elyasi in European Journal of Clinical Pharmacology
    Article 01 December 2022
  8. The toxic effects of anabolic steroids “nandrolone decanoate” on cardiac and skeletal muscles with the potential ameliorative effects of silymarin and fenugreek seeds extract in adult male albino rats

    Background

    Anabolic steroids (AS) are commonly abused by body builders and athletes aiming to increase their strength and muscle mass but...

    Dalia Abd Elwahab Hassan, Sherien S. Ghaleb, ... Mostafa Abdallah Abdel Alim in BMC Pharmacology and Toxicology
    Article Open access 15 March 2023
  9. Silymarin ameliorates peritoneal fibrosis by inhibiting the TGF-β/Smad signaling pathway

    Peritoneal dialysis (PD) is the mainstay of treatment for renal failure replacement therapy. Although PD has greatly improved the quality of life of...

    Yingwen Bai, Lulu Wang, ... Weihong Ge in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 13 April 2023
  10. Silymarin-Encapsulated Xanthan Gum–Stabilized Selenium Nanocarriers for Enhanced Activity Against Amyloid Fibril Cytotoxicity

    The accumulation of amyloid-beta at the neuronal sites is a major pathological hallmark involved in the etiology of Alzheimer’s disease. To reduce...

    Vanshul Saini, Ajit Singh, ... A. K. Yadav in AAPS PharmSciTech
    Article 26 April 2022
  11. Silymarin constrains diacetyl-prompted oxidative stress and neuroinflammation in rats: involvements of Dyn/GDNF and MAPK signaling pathway

    Neuroinflammation, a major component of many CNS disorders, has been suggested to be associated with diacetyl (DA) exposure. DA is commonly used as a...

    Manar Mohammed El Tabaa, Hamdi M. Aboalazm, ... Naglaa Fathy Khedr in Inflammopharmacology
    Article Open access 02 April 2022
  12. Exploring the potential of silymarin-loaded nanovesicles as an effective drug delivery system for cancer therapy: in vivo, in vitro, and in silico experiments

    We aimed to perform a comprehensive study on the development and characterization of silymarin (Syl)-loaded niosomes as potential drug delivery...

    Mohammad Reza Hajinezhad, Maryam Roostaee, ... Saman Sargazi in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 17 April 2024
  13. Mesoporous silica coated SPIONs containing curcumin and silymarin intended for breast cancer therapy

    Introduction

    Super-paramagnetic iron oxide nanoparticles (SPIONs) are known as promising theranostic nano-drug carriers with magnetic resonance...

    Soosan Sadegha, Reyhaneh Varshochian, ... Rassoul Dinarvand in DARU Journal of Pharmaceutical Sciences
    Article 05 October 2022
  14. Silymarin mitigates bile duct obstruction-induced cholemic nephropathy

    Bile duct obstruction or cholestasis can occur by several diseases or xenobiotics. Cholestasis and the accumulation of the bile constituents in the...

    Mohammad Mehdi Ommati, Omid Farshad, ... Reza Heidari in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 04 February 2021
  15. Rosuvastatin attenuates total-tau serum levels and increases expression of miR-124-3p in dyslipidemic Alzheimer's patients: a historic cohort study

    microRNAs are candidate diagnostic biomarkers for Alzheimer's disease. This study aimed to compare Silymarin with Rosuvastatin and placebo on...

    Farnoosh Usefi, Auob Rustamzadeh, ... Fatemeh Moradi in Metabolic Brain Disease
    Article 19 June 2024
  16. Integrating Artificial Intelligence with Quality by Design in the Formulation of Lecithin/Chitosan Nanoparticles of a Poorly Water-Soluble Drug

    The aim of the current study is to explore the potential of artificial intelligence (AI) when integrated with Quality by Design (QbD) approach in the...

    Marwa H. S. Dawoud, Islam S. Mannaa, ... Nabila M. Sweed in AAPS PharmSciTech
    Article Open access 08 August 2023
  17. A Quality by Design Paradigm for Albumin-Based Nanoparticles: Formulation Optimization and Enhancement of the Antitumor Activity

    Purpose

    Albumin nanoparticles are promising carriers for therapeutic agents, owing to their biocompatibility, safety, and versatility in fabrication....

    Marwa H. S. Dawoud, Amira Abdel-Daim, ... Nabila M. Sweed in Journal of Pharmaceutical Innovation
    Article Open access 08 May 2023
  18. In Silico Interactions of Natural and Synthetic Compounds with Key Proteins Involved in Alzheimer’s Disease: Prospects for Designing New Therapeutics Compound

    Memory impairment is a result of multiple factors including amyloid-beta (Aβ) accumulation. Several receptors are mediated for Aβ transport and...

    Mehran Ebrahimi Shah-abadi, Armin Ariaei, ... Vahid Tavakolian Ferdousie in Neurotoxicity Research
    Article 22 April 2023
  19. RETRACTED ARTICLE: Neuronal degeneration and oxidative stress in the SNc of 6-OHDA intoxicated rats; improving role of silymarin long-term treatment

    Progressive loss in dopaminergic neurons (DA) of substantia nigra pars compacta (SNc) leads to Parkinson’s disease with a hypothesis of oxidative...

    Rasool Haddadi, Shahla Eyvari-Brooshghalan, ... Sara Ami Ahmadi in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 27 July 2020
  20. Modulatory Effect of Silymarin on Apoptosis in Testosterone -Induced Benign Prostatic Hyperplasia in Rats

    Benign prostatic hyperplasia (BPH) is considered a normal part of the aging process in men, and is characterized by an imbalance between cell...

    Nahla E. El-Ashmawy, Eman G. Khedr, ... Nada N. Helmy in Pathology & Oncology Research
    Article 04 January 2020
Did you find what you were looking for? Share feedback.